VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1652332
Sex: F
Age:
State: VA

Vax Date: 03/06/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210507; Test Name: biopsy; Result Unstructured Data: Test Result:granuloma annulare

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Within a few days of receiving my first vaccine (Pfizer EN6201), I got a rash on my right thigh (5" x 9 1/2") and on my right upper abdomen.; The rashes were itchy and warm to the touch; The rashes were itchy and warm to the touch; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Right on 06Mar2021 14:30 (Lot Number: EN6198) as single dose (at the age of 71-years-old) for COVID-19 immunization. Medical history included allergies/sinus, high blood pressure, (allergies to) sulfa, and suspected granuloma annulare on 23Feb2021. The patient was not pregnant. Concomitant medications were taken but not specified ("This field will not allow me to list all meds"). The patient previously took doxycycline and tetracycline and experienced allergies. No other vaccine in four weeks. Patient reported that, "Within a few days of receiving my first vaccine (Pfizer EN6201, pending clarification), I got a rash on my right thigh (5" x 9 1/2") and on my right upper abdomen. The rashes were itchy and warm to the touch. On 23Feb2021, I began treatment for suspected granuloma annulare. That diagnosis was confirmed by a biopsy on 07May2021. I have been treated with topical ointments and injections, but the rashes have not abated. Furthermore, I continue to acquire new granuloma annulare spots (left groin, left thigh, left ankle). While I have had a localized granuloma annulare in the past, it had abated prior to the onset of this generalized granuloma annulare." The patient underwent lab tests and procedures which included biopsy: granuloma annulare on 07May2021. Therapeutic measures were taken as a result of the events which included topical ointments, injections "(I think it was ster." The events resulted in Doctor or other healthcare professional office/clinic visit. The patient had not recovered from the events. The events were considered as serious (medically significant). Not diagnosed with COVID prior vaccination. Not COVID tested post vaccination.

Other Meds:

Current Illness:

ID: 1652333
Sex: F
Age:
State: NJ

Vax Date: 05/15/2021
Onset Date: 05/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210428; Test Name: Polymerase Chain Reaction (PCR); Test Result: Negative ; Comments: Nasal swab

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Important Hair Loss; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the right arm on 15May2021 as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had no known allergies. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) taken for an unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Apr2021, the patient underwent COVID-19 test Polymerase Chain Reaction (PCR) and the result was negative. On 17May2021, the patient experienced hair loss which was important. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. The clinical outcome of the event hair loss was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1652334
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Headaches; Feeling the need to vomit; This is a spontaneous report from a non-contactable consumer, the patient. A 48-year-old, non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 48-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date, the patient experienced headaches and feeling the need to vomit. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of events. The clinical outcome of events headaches and feeling the need to vomit were recovering at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652335
Sex: F
Age:
State:

Vax Date: 04/29/2021
Onset Date: 05/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data: Test Name: Heart rate; Result Unstructured Data: Test Result:Heart rate increased; Comments: racing heart rate

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Heart palpitations/racing heart rate when not active; Heart palpitations/racing heart rate when not active; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0179) via an unspecified route of administration in the left arm on 29Apr2021 at 09:30 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not have any allergies to food, medications, or other products. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0158) via an unspecified route of administration in the left arm on 15Apr2021 at 10:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08May2021 at 20:00, the patient experienced heart palpitations/racing heart rate when not active. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of reported events and included treatment with unknown medications and also monitoring heart activity with wearable device. The clinical outcome of the events heart palpitations/racing heart rate when not active was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652336
Sex: F
Age:
State: FL

Vax Date: 05/14/2021
Onset Date: 05/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Arm had extreme pain; Fatigue got really bad/ extremely worn out; Little itchy; Not feeling well; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the arm left on 14May2021 at 15:30 as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis. The patient was allergic to penicillin. Concomitant medication included upadacitinib (RINVOQ) and Breo (MANUFACTURER UNKNOWN) for unknown indication taken on unknown date and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously taken hydroxychloroquine (MANUFACTURER UNKNOWN) and had allergy. On 19May2021, the patient experienced extreme arm pain for almost 2 days, fatigue got really bad/ extremely worn out after about a week, little itchy and not feeling well. The patient reported that she missed a day of work so far. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme arm pain for almost 2 days, fatigue got really bad/ extremely worn out after about a week, little itchy and not feeling well was not resolved at the time of this report.

Other Meds: RINVOQ

Current Illness:

ID: 1652337
Sex: F
Age:
State: VA

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Itchy eyes and whole body and vision slightly blurred; Itchy eyes and whole body and vision slightly blurred; Itchy eyes and whole body and vision slightly blurred; This is a spontaneous report from contactable consumer (patient). A 40-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot number: EW0173; Expiration date: not provided) via an unspecified route of administration on 05May2021 at 10:00 (age at vaccination 40-year-old) as dose 1, single for covid-19 immunization Doctor Office / Urgent Centre. The patients medical history and concomitant medications were not reported. Patient did not have any known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Patient took second dose of BNT162B2, Lot number: EW0185 on 26May2021 for Covid-19 immunization. On 05May2021 at 14:00, patient experienced itchy eyes and whole body and vision slightly blurred. The patient did not receive any treatment for adverse events. The outcome of event was not recovered. Follow-up attempts completed. No further information expected.

Other Meds:

Current Illness:

ID: 1652338
Sex: F
Age:
State: MD

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: mild low-grade fever; headache; hard to stand energy wise; pain in uterus/ovary areas within 8 hours of vaccine; shakiness until two days after; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 24May2021 at 15:15 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was allergic to gluten which had some small impact but she could eat it. Concomitant medications included ascorbic acid, herbal nos, levoglutamide, lysine, magnesium, manganese, retinol, riboflavin, selenium, tocopherol, zinc (AIRBORNE), vitamin D (MANUFACTURER UNKNOWN) and women's multivitamins (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 03May2021 at 15:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 23:15, within 8 hours of vaccine, the patient experienced pain in uterus/ovary areas, it was not related to her period cycle as that had been over two weeks prior and the pain lasted the following day, it was intensified when breathing deeply or sucking in stomach. On 24May2021, the patient experienced shakiness until two days after. On 25May2021, the day after the vaccine not until 5 hours into work, the patient experienced mild low-grade fever, headache and hard to stand energy wise, the headache was intensified when vertical through the rest of that day. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain in uterus/ovary areas and shakiness were resolved on 25May2021 and 26May2021 respectively, while the outcomes of mild low-grade fever, headache and hard to stand energy wise were resolved on an unknown date on May2021. No follow-up attempts are possible. No further information is expected.

Other Meds: AIRBORNE; VITAMIN D NOS

Current Illness:

ID: 1652339
Sex: F
Age:
State: ME

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: I got red on my jaw and down my neck and it was kind of swollen under my jaw; I got red on my jaw and down my neck and it was kind of swollen under my jaw; This is a spontaneous report from a contactable consumer (patient) reported for herself that a 72-year-old female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, solution for injection, batch/lot number: unknown, Expiry Date: Unknown), via an unspecified route of administration in right arm on 24May2021 as single dose for COVID-19 immunisation. Patient stated that it looks like EW or CW she could not read the writing 0185 and expiration date: nothing written on the back of the card. The patient's medical history included blood pressure high, thyroid, these little pin point rash things on her forehead. She had it before years ago and was told it was shingles associated with a migraine headache. She have not had it for several years. It went away after a couple of days. A few months back she had a swollen gland in that same area she thought it might be long Covid. If it was an allergy it lasted a few days and she took Benadryl. Doctor told her to take the second dose and to take 50 mg of Benadryl before getting the second dose. Concomitant medications were not reported. On 24May2021, eight to nine hours after the shot, the patient noticed that I got red on my jaw and down my neck and it was kind of swollen under my jaw. It was explained that she got the Pfizer vaccine day before yesterday and about might be 8 or 9 hours after she got red on her jaw and down her neck and it was kind of swollen under her jaw and so she was just wondering if she only get the one shot, was that considered an adverse effect that she should not get the second shot. So, if she only get the first shot how much was she protected. Upon Follow up (02Jun2021), patient received the first dose of the Pfizer Covid 19 vaccine on 24May2021. She reported that she got like for one thing she got these little pin point rash things on my forehead. She had it before years ago and was told it was shingles associated with a migraine headache. She haven't had it for several years. It went away after a couple of days. Eight to nine hours after the shot, She got redness on face and some swelling there a little bit. Does that sound like an allergy? Should she get the second shot? What protection, the percentage, if you only got the first shot? She think she had Covid back at the beginning before they were testing for it. She was wondering if she can go without that second shot. A few months back she had a swollen gland in that same area she thought it might be long Covid. If it was an allergy it lasted a few days and she took Benadryl. She called the doctor already and she told me to take the second dose and to take 50mg of Benadryl before getting the second dose. Patient received liquid Benadryl as treatment. The outcome of the events was unknown. Limited information was available over the call. Information about the Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652340
Sex: M
Age:
State: OH

Vax Date: 04/26/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Sore on left side of tongue; This is a spontaneous report from a contactable healthcare professional, the patient. A 51-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the right arm on 26Apr2021 at 16:00 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. Medical history included heart disorder, joint/pain back and neck, hypertension (htn), hyperlipidemia, angina, diabetes, and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient received unspecified medication within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously took (diclofenac) VOLTAREN and (topiramate) TOPAMAX; both for an unspecified indication from an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER8730) via an unspecified route of administration in the right arm on 29Mar2021 at 16:00 (at the age of 51-year-old), as a single dose for COVID-19 immunisation. On 24May2021 at 01:00, the patient experienced sore on the left side of the tongue. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with unspecified medication (Med). Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event sore on left side of tongue was not recovered at the time of this report.

Other Meds:

Current Illness:

ID: 1652341
Sex: M
Age:
State: TN

Vax Date: 05/15/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Generalized hives; itching/hives persistwith little improvement 15 days afterreceiving vaccine; This is a spontaneous report from a contactable physician. A 14-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 15May2021 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient had no known allergies. The patient did not receive other medications in two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021, the patient experienced generalized hives within few hours of receiving vaccine, itching/hives persisted with little improvement 15 days after receiving vaccine. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events and included treatment with prednisone. The clinical outcome of the events generalized hives, itching/hives persisted was recovering. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1652342
Sex: F
Age:
State:

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: extreme chest pain for two hours; Struggled to breath with all over lung; This is a spontaneous report from a non-contactable consumer, the patient. A 31-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the arm left on 24May2021 at 08:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via an unspecified route of administration in the arm left on 03May2021 at 08:15 (at the age of 31-year-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25May2021 at 12:00, a little after 24 hours, the patient experienced extreme chest pain for two hours and struggled to breath with all over lung and chest pain. The event resulted in emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event extreme chest pain and Struggled to breath with all over lung was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652343
Sex: F
Age:
State: MI

Vax Date: 05/25/2021
Onset Date: 05/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 20210526; Test Name: body temperature; Result Unstructured Data: Test Result:101.5 Units:{DF}; Comments: at 12:00 AM

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Im also having ear pains,; Have a 101.5 fever; A headache; Muscle aches; Weakness everywhere; Tiredness; chills; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0187), via an unspecified route of administration in the right arm on 25May2021 at 17:30 (at the age of 19 years-old) as single dose for COVID-19 immunisation. The patient had history of known allergies to baby oil (mineral oil). The patient did not receive any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 26May2021 at 00:00, the patient experienced 101.5 fever, a headache, muscle aches, weakness everywhere, tiredness, chills and also having ear pains that felt like an ear infection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcomes of 101.5 fever, a headache, muscle aches, weakness everywhere, tiredness, chills and also having ear pains were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652344
Sex: F
Age:
State: CA

Vax Date: 05/25/2021
Onset Date: 05/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210526; Test Name: Body temperature; Result Unstructured Data: Test Result:99.9F; Comments: 99.9F temperature

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Body aches/Body pains; Chills; 99.9F temperature; Arm which received inoculation was sore; Severe headache; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0185) via an unspecified route of administration in the left arm on 25May2021 at 14:15(at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to sulfa and penicillin. Concomitant medications included gabapentin (GABAPENTINA), olanzapine (ZYPREXA), alprazolam (XANAX); all for an unspecified indication and unknown start date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0167) via an unspecified route of administration in the left arm on 03May2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation and also took novocaine (MANUFACTURER UNKNOWN) and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 26May2021 at 03:41, the patient experienced severe headache and at 03:45, the patient experienced body aches, body pains, chills,99.9F temperature for 11 hours and arm which received inoculation was sore and unable to lift it due to severe pain and soreness. The patient did not receive any treatment for the events. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. On 26May2021 at 03:45, patient body temperature was measured and result was 99.9F. The clinical outcome of headache, body aches, body pains, chills, 99.9F temperature and arm which received inoculation was sore were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: GABAPENTINA; ZYPREXA; XANAX

Current Illness:

ID: 1652345
Sex: F
Age:
State: CO

Vax Date: 05/11/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: Period 1 week late; This is a spontaneous report from a non-contactable consumer, the patient. A 26-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0182) via an unspecified route of administration in the left arm on 11May2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0172) via an unspecified route of administration in the left arm on 20Apr2021 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24May2021, the patient experienced period 1 week late. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported event. The clinical outcome of the event period 1 week late was resolved on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652346
Sex: F
Age:
State: FL

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Very lightly picked nose, not scratching the skin, and got a nose bleed; Nose was dry; This is a spontaneous report from a non-contactable other healthcare professional, the patient. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo171) via an unspecified route of administration in the left arm on 24May2021 at 10:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included known allergies to penicillin, sulfa drugs and pineapple. Concomitant medications included vitamin b nos (VITAMIN B), ascorbic acid (VITAMIN C), vitamin d nos (VITAMIN D), magnesium (MANUFACTURER UNKNOWN), calcium (MANUFACTURER UNKNOWN), curcumin (MANUFACTURER UNKNOWN) and multi (as reported); all for unspecified indication from unknown date. The patient previously took ammonium chloride;diphenhydramine hydrochloride;menthol;sodium citrate (COSINE) for unspecified indication from unknown date and experienced drug allergy. The patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ewo175) via an unspecified route of administration in the left arm on 03May2021 at 10:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The clinical course was reported as follows: on 25May2021 at 11:00, the patient very lightly picked nose, not scratching the skin, and got a nose bleed. It lasted a minute or so. It was enough to drop out, not just a little residue. The patient clotted quickly and it stopped with pressure. The patient's nose was dry and got this kind of nosebleeds as a little kid, but this was excessive and patient believed it was related to the shot. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event very lightly picked nose, not scratching the skin, and got a nose bleed was recovered on 25May2021. The clinical outcome of the event nose was dry was recovered on an unknown date of May2021. No follow-up attempts are possible. No further information is expected

Other Meds: VITAMIN B [VITAMIN B NOS]; VITAMIN C [ASCORBIC ACID]; VITAMIN D [VITAMIN D NOS]; MAGNESIUM; CALCIUM; CURCUMIN

Current Illness:

ID: 1652347
Sex: F
Age:
State: PA

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Numbness of face 30 mins or less after dosage was administered; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 24May2021 at 13:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient received medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 14:00, the patient experienced numbness of face for 30 mins or less after vaccination was administered. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event numbness of face was recovered in May2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652348
Sex: F
Age:
State: TX

Vax Date: 04/30/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Urinary tract infection; This is a spontaneous report from a contactable consumer, the patient. A 34-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8730) via an unspecified route of administration in the left arm on 30Apr2021 (at age of 34-years old) at 08:30 as a single dose for COVID-19 immunisation. Medical history included the patient had known allergies which included occasional rash with shell fish. The patient did not receive any medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. On 15May2021 at 21:30, the patient experienced urinary tract infection. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of urinary tract infection and included treatment with amoxillin. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event urinary tract infection was not recovered at this time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652349
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Menstrual cycles are extremely heavier; Menstrual cycles are extremely heavier, painful and irregular.; Menstrual cycles are extremely heavier, painful and irregular.; Menstrual cycles are every 2 weeks; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old, non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date and second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 05Apr2021(at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in 2021, the patient's menstrual cycles are extremely heavier, painful, irregular and had menstrual cycles every 2 weeks. The patient did not receive any treatment for the reported events. The clinical outcome of the events extremely heavier, painful, irregular and menstrual cycles every 2 weeks were unknown at the time of this report. No follow-up attempts are possible; Information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652350
Sex: F
Age:
State: NY

Vax Date: 04/07/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Very heavy period; This is a spontaneous report from a contactable consumer, the patient. A 47-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration in the left arm on 07Apr2021 at 11:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. Medical history included known allergy to sulfa drugs. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267) via an unspecified route of administration in the right arm on 17Mar2021 at 11:15 (at the age of 47-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021 at 17:00, the patient experienced very heavy period and had been bleeding through super plus tampons at a rate of 1 tampon per hour or two for 5 days. For the past year she had very light periods. The patient reported that it was not normal. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event very heavy period was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL

Current Illness:

ID: 1652351
Sex: F
Age:
State: IA

Vax Date: 05/21/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: My menstrual cycle started 9 days early.; This is a spontaneous report from a non-contactable consumer, the patient. A 45-year-old non pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0187), via an unspecified route of administration in left arm on 21May2021 at 17:30 as single dose for COVID-19 immunisation. Medical history included allergy to sulfonamide and latex allergy. The patient did not receive any medication within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, patient had not been tested for COVID-19. On 25May2021, patient experienced menstrual cycle which started early. No therapeutic measures were taken as a result of the events. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the event menstrual cycle started early was not resolved at the time of the report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652352
Sex: M
Age:
State:

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Lymph nodes under arms were very sore; This is a spontaneous report from a non-contactable consumer, the patient. A 55-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 0151) via an unspecified route of administration on 05Apr2021 (at the age of 55-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown date. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN), febuxostat (MANUFACTURER UNKNOWN), pantoprazole (MANUFACTURER UNKNOWN) and gabapentin (MANUFACTURER UNKNOWN), all taken from unknown dates for unspecified indications. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021, the patient experienced very sore lymph nodes under arms. The event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event very sore lymph nodes under arms was resolved on an unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMIN D NOS; FEBUXOSTAT; PANTOPRAZOLE; GABAPENTIN

Current Illness:

ID: 1652353
Sex: F
Age:
State: CA

Vax Date: 05/19/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: General pain; Headache without fever; Persistent pain in the left arm; This is a spontaneous report from a contactable consumer, the patient. A 44-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0177) via an unspecified route of administration in the arm left on 19May2021 at 13:15(at the age of 44-year-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroidism and penicillin allergy. Concomitant medications included hpv vaccine vlp rl1 9v (yeast) (GARDASIL 9) on left arm and levothyroxine sodium 50ug (EUTHYROX), all from unknown dates for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8735) via an unspecified route of administration in the arm left on an unknown date as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date in May2021, the patient experienced persistent pain in the left arm. On 20May2021 at 03:00 in the night of second shot of vaccine, the patient experienced general pain and headache without fever. However, the headache and persistent pain in the left arm had not been improved and it was very painful. The patient took pain killers and Tylenol as treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event persistent pain in the left arm, general pain and headache without fever was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: Euthyrox

Current Illness:

ID: 1652354
Sex: M
Age:
State:

Vax Date: 05/12/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Developed Shingles two weeks after the first pfizer vaccine dose.; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 12May2021 (at the age of 35-years-old), as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021, the patient developed shingles two weeks after the first vaccine dose. The patient never had shingles before. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included treatment with VALTREX. The clinical outcome of the event shingles two weeks after the first vaccine dose was resolving, at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652355
Sex: F
Age:
State: IL

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: Sharp chest pain; "Extremely painful that it woke me up and made it impossible to sleep"; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration in the left arm on 24May2021 at 12:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history included environmental allergy and sulfonamide allergy. Concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (NORLESTRIN FE) and levocabastine hydrochloride (ZYRTEC); from an unknown date for an unknown indication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown) via an unspecified route of administration on the left arm on 05May2021 at 12:00 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25May2021 at 00:00, the patient experienced sharp chest pain on left side only. Extremely painful that it woke the patient up and made it impossible to sleep. Began 12 hours after second dose and lasted 24 hours. It did hurt to take in a deep breath. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events sharp chest pain and "extremely painful that it woke the patient up and made it impossible to sleep" were recovered on 26May2021. The batch/lot number for BNT162b2, was not provided and will be requested during follow up.

Other Meds: NORLESTRIN FE; ZYRTEC [LEVOCABASTINE HYDROCHLORIDE]

Current Illness:

ID: 1652356
Sex: F
Age:
State:

Vax Date: 05/19/2021
Onset Date: 01/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: severe/immobilizing back and neck pain (lasted for 2 days); still having severe neck pain intermittently; within 24 hours, severe shoulder pain; Severe pain in arm several minutes after receiving vaccine;; severe/immobilizing back and neck pain (lasted for 2 days); still having severe neck pain intermittently; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO176) via an unspecified route of administration in the left arm on 19May2021 at 19:00 (at the age of 23-year-old) as a single dose for COVID-19 immunisation. Medical history included arthritis and gallbladder disease. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included sertraline (MANUFACTURER UNKNOWN), bupropion hydrochloride (WELLBUTRIN), lamotrigine (LAMICTAL) and gabapentin (MANUFACTURER UNKNOWN);all from unknown dates for unknown indication, unknown if ongoing. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 19May2021 at 19:15, the patient experienced severe pain in arm several minutes after receiving vaccine, within 24 hours, severe shoulder pain, within 48 hours severe/immobilizing back and neck pain (lasted for 2 days), was still having severe neck pain intermittently. No therapeutic measures were taken as a result of adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events severe pain in arm, severe shoulder pain neck pain and back pain was recovered with sequelae on an unknown date in May2021.

Other Meds: SERTRALINE; WELLBUTRIN; LAMICTAL; GABAPENTIN

Current Illness:

ID: 1652357
Sex: F
Age:
State: TX

Vax Date: 05/21/2021
Onset Date: 05/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Pain in arm at injection site; swollen/painful lymph node under arms; fatigue; nausea; fever; chills; brain fog; dizziness; This is a spontaneous report from a non-contactable consumer, the patient. A 32-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 21May2021 at 08:30(at the age of 32-year-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not have any allergies to medications, food, or other products. Concomitant medications included fluticasone propionate (FLONASE), minerals nos, vitamins nos (PRENATAL VITAMINS) and magnesium carbonate (MAGNESIUM) taken from unknown date for unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23May2021 the patient experienced pain in arm at injection site, swollen/painful lymph node under arms, fatigue, nausea, fever, chills, brain fog and dizziness. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events pain in arm at injection site, swollen/painful lymph node under arms, fatigue, nausea, fever, chills, brain fog and dizziness were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: FLONASE [FLUTICASONE PROPIONATE]; PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]; MAGNESIUM

Current Illness:

ID: 1652358
Sex: F
Age:
State:

Vax Date: 03/24/2021
Onset Date: 03/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Excessive thirst; This is a spontaneous report from a non-contactable physician, the patient. A 40-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8733) via an unspecified route of administration on 24Mar2021 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 24Mar2021, the patient experienced excessive thirst. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of excessive thirst was recovered on unknown date in 2021. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652359
Sex: F
Age:
State:

Vax Date: 05/06/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: Severe depression; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 06May2021(at the age of 33-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications were not reported. On an unknown date in May2021, the patient experienced severe depression. The clinical outcome of the event severe depression was unknown at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652360
Sex: F
Age:
State: ND

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: severe chills; headache; muscle aches; joint aches; back pain; nausea; injection site pain; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration on 24May2021 at 15:15 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included unspecified adverse reaction to anaesthesia. The patient previously took hydrocodone on an unknown date for an unknown indication and experienced drug allergy. Concomitant medication included LAMISIL, taken for an unknown indication and taken within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 24May2021, within 2 hours of vaccine administration, the patient experienced injection site pain. On 25May2021, 24 hours after administration of vaccine, the patient experienced severe chills, headache, muscle aches, joint aches, back pain, and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injection site pain, severe chills, headache, muscle aches, joint aches, back pain, and nausea were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LAMISIL

Current Illness:

ID: 1652361
Sex: F
Age:
State: OR

Vax Date: 05/22/2021
Onset Date: 05/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: Dizziness; Vertigo; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0185) via an unspecified route of administration in the left arm on 22May2021 at 09:30 (at the age of 30-years-old) as a single dose for COVID-19 immunization. Other medical history reported as none. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EW0164) via an unspecified route of administration in the left arm on 22May2021 at 09:30 (at the age of 30-years-old) as a single dose for COVID-19 immunization. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23May2021, the patient experienced dizziness/vertigo. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events which included treatment with Flonase. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events dizziness/vertigo was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652362
Sex: F
Age:
State: CA

Vax Date: 03/07/2021
Onset Date: 03/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210513; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Injection site pain

Symptoms: hives; shingles; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of unknown age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 07Mar2021 as a single dose for COVID-19 immunisation. Medical history included arthritis and blood pressure high. Concomitant medication was reported as none . The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EN5318) via an unspecified route of administration in the right arm on 14Feb2021 as a single dose for COVID-19 immunisation to the vaccination. The patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Mar2021 the patient experienced hives and shingles. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the event which included treatment zyrtec and pepcid for hives. Antiviral for shingle . On 13May2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. The clinical outcome of the event hives and shingles was resolving. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652363
Sex: M
Age:
State:

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Extremely fatigued; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 56-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE: Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 at 15:45 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 18:00, the patient experienced extremely fatigued and sore arm. The patient did not receive any treatment for the events. The clinical outcome of the events of extremely fatigued and sore arm was recovered on an unknown date. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652364
Sex: F
Age:
State: NY

Vax Date: 05/24/2021
Onset Date: 05/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Injections site is swollen and hot to touch; Injections site hot to touch; Very hard large lump under the skin very red very painful; Very hard large lump under the skin very red very painful; Very hard large lump under the skin very red very painful; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0180) via an unspecified route of administration in the left arm on 24May2021 at 09:30 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included blood clotting disorder and COVID-19. The patient was not allergic to medications, food, or other products. Prior to vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) and acetylsalicylic acid (aspirin) (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26May2021 at 10:00, the patient experienced injections site swelling and hot to touch and had a very hard large lump under the skin which was very red and very painful. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events injections site swollen and hot to touch and had a very hard large lump under the skin which was very red and very painful were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEVOTHYROXINE; ACETYLSALICYLIC ACID

Current Illness:

ID: 1652365
Sex: M
Age:
State: CA

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: At 48 hoursafter injection, the swollen area of neck is currently the size of an orange, making it painful and difficultto turn neck.; inexplicable, painful, noticeable swelling appeared on right hand side of neck, below the ear; experienced a numbness in left armfrom elbow to pinky; Pain in left arm around injection site; Headache occurred within 12 hours of injection and is starting to subside at 48 hours.; This is a spontaneous report from a contactable consumer, the patient. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0186) via an unspecified route of administration in the left arm on 24May2021 at 17:15(at the age of 17-year-old) as a single dose for COVID-19 immunisation. Medical history included cystic acne previously treated with accutane. The patient did not receive any medications within two weeks of vaccination. The patient previously received isotretinoin(ACCUTANE) from an unknown date for cystic acne. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 17:15 immediately following injection, the patient experienced a numbness in left arm that is the vaccination site arm from elbow to pinky, after 48 hours, numbness continues but was lessening. On 24May2021, the patient experienced pain in left arm around injection site, but was improving. On 24May2021 within 12 hours of injection, the patient experienced headache and started to subside at 48 hours. On 26May2021 at 05:15 roughly 36 hours after vaccination, the patient experienced inexplicable, painful, noticeable swelling appeared on right hand side of neck, below the ear. On 26May2021 at 15:15 at 48 hours after injection, the patient experienced the swollen area of neck was in the size of an orange, making it painful and difficult to turn neck. So the patient called nurseline with concern and determined to monitor for next 24 hours from home. The patient mentioned that he will schedule appointment if worsens or additional symptoms arise. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. The clinical outcome of the event headache and pain in left arm around injection site was recovering while that of numbness in left arm from elbow to pinky, inexplicable, painful, noticeable swelling appeared on right hand side of neck, below the ear and painful and difficult to turn neck were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652366
Sex: F
Age:
State: AL

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: This is a spontaneous report from a non-contactable consumer, the patient. A 30-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 24May2021 at 12:15 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy and corn allergy. Concomitant medications were not received within two weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24May2021 at 14:15, the patient experienced headache, nausea, dizziness, trouble sleeping, fever, cold sweats, shakiness in hands, pain at injection site, rapid heartbeat, fatigue, coughing, mental fog and light sensitivity. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headache, nausea, dizziness, trouble falling asleep, fever, cold sweat, shaking of hands, vaccination site pain, heart beats increased, fatigue, coughing, foggy feeling in head and light sensitivity to eye was not recovered at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652367
Sex: F
Age:
State: MO

Vax Date: 05/24/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: 48 hours post vaccine my top teeth became very sensitive pressure feeling. After 1 500 mg Tylenol the pain let up but still tight & sensitive to liquids.; chills; This is a spontaneous report from a non-contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 24May2021 at 14:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) taken for unknown indication taken within 2 weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 03May2021 at 13:15 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 25May2021 at 14:00 24 hours post vaccine heavy feeling, chills, she took Tylenol 500mg and she started to sweat & feel much better.0n 26May2021 48 hours post vaccine her top teeth became very sensitive pressure feeling. She took 500 mg Tylenol the pain let up but still tight & sensitive to liquids. Therapeutic measures were taken as a result of the events chills, sensitive teeth with Tylenol 500mg. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome for the events heavy feeling, chills, top teeth became very sensitive pressure feeling and the pain let up but still tight & sensitive to liquids were resolving at the time of the report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected

Other Meds: SERTRALINE

Current Illness:

ID: 1652368
Sex: F
Age:
State: MI

Vax Date: 05/23/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Numbness in hands; numbness in feet; tingling in hands and feet; This is a spontaneous report from a contactable other healthcare professional, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via intramuscular route of administration in the right arm on 23May2021 at 15:00 (at the age of 22-years-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history and known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included birth control from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021, the patient experienced numbness and tingling in the hands and feet. It was unknown whether the patient received any treatment for the reported events. The events did not result in any doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events numbness and tingling in the hands and feet was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652369
Sex: F
Age:
State: OH

Vax Date: 04/21/2021
Onset Date: 04/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210503; Test Name: EKG; Result Unstructured Data: Test Result:blood pressure was increased and heart rate was...; Comments: blood pressure was increased and heart rate was increased

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Stress; , racing andpalpitations are not normal stressresponses; Blood pressure was increased; Heart rate was increased; . I was prescribedhydroxyzine for possible anxiety.; Heart felt like it was racing for more than 2 hours; Chest pain primarily in the right side; I was unable to run for exercise as I normally do because I experienced increased pain after a couple of blocks; 2 days after my second dose, Inoticed swelling of lymph nodes in myneck (right side).; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the right arm on 21Apr2021 at 11:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included none. The patient did not receive any medication within two weeks of vaccination. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the right arm on 31Mar2021 at 11:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23Apr2021 at 07:00, the patient experienced swelling of lymph nodes in neck, right side. About 4 days after second dose, the lymph node swelling decreased some, went to urgent care on April 23. On 25Apr2021, the patient experienced chest pain primarily in the right side, was unable to run for exercise as normally did because she experienced increased pain after a couple of blocks. A normal run for her was 5 miles. On 30Apr2021, the patient experienced around midnight, she was in bed and her heart felt like it was racing for more than 2 hours. 03May2021, the patient experienced racing again, this was during the day and she was under stress, racing and palpitations were not normal stress responses for her. She went to urgent care did an EKG, blood pressure was increased and heart rate was increased. She reported no previous diagnosed anxiety, and also stated that chest pain remained. She continued to experience chest pain on and off as of 27May2021. On 03May2021, the patient underwent EKG and the result was blood pressure was increased and heart rate was increased. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the event anxiety and included treatment with hydroxyzine. Therapeutic measures were taken as a result of the event chest pain and included treatment with naproxen. The clinical outcome of the events chest pain, swelling of lymph nodes in neck, was unable to run for exercise as normally did because she experienced increased pain after a couple of blocks, heart felt like it was racing, stress, palpitations, blood pressure was increased and heart rate was increased was recovered with sequelae. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652370
Sex: F
Age:
State: PA

Vax Date: 05/18/2021
Onset Date: 05/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Broke out in a red rash / near arm injection site; Broke out in a itchy rash / near arm injection site; Red itchy rash on legs and partial torso; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWO177) via an unspecified route of administration in the left arm on 18May2021 at 09:00 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. Medical history included cystic fibrosis, an allergy to strawberries, bee venom and latex. The patient previously received sulfa (sulfonamide) and opiates and experienced a drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included omeprazole (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 22Apr2021 at 13:45 (at the age of 51-years-old), as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 19May2021 at 17:00, few hours after the second vaccine, the patient reported that she "broke out in a red itchy rash / near arm injection site, legs and partial torso." Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events broke out in a red itchy rash / near arm injection site, legs and partial torso were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: OMEPRAZOLE

Current Illness:

ID: 1652371
Sex: F
Age:
State: SC

Vax Date: 05/26/2021
Onset Date: 05/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: Waking up the next morning after my first dose, every muscle and bone in my body has the same pain I had on the injection site/ whole body muscle soreness; Waking up the next morning after my first dose, every muscle and bone in my body has the same pain I had on the injection site/ Achey joints and bone; Waking up the next morning after my first dose, every muscle and bone in my body has the same pain I had on the injection site.; I also have an intense headache,; Achey joint; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0177) via an unspecified route of administration in the right arm on 26May2021 at 10:00 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. Medical history included iron deficiency anemia, plantar fasciitis, COVID-19, allergy to animal (cat), pollen allergy and spice (cinnamon). Concomitant medications were not reported. The patient previously received ciprofloxacin (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27May2021, after waking up the next morning after the first dose the patient's every muscle and bone in the body had the same pain which she had on the injection site. The patient also had an intense headache, whole body muscle soreness, achy joints and bones and nausea. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events every muscle and bone in her body had the same pain which she had on the injection site, intense headache, whole body muscle soreness, achy joints and bones and nausea were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652372
Sex: F
Age:
State: CA

Vax Date: 05/03/2021
Onset Date: 05/04/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Pain in chest bending over; Shortness breath 4th day; Injection side swelling; Injection site redness; Injection site pain; Chills; Fever; Tightening/numbness injection site ongoing; Tightening/numbness injection site; This is a spontaneous report from a contactable consumer, the patient. A 43-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167) via an unspecified route of administration in the left arm on 03May2021 at 10:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included iron deficient anemia and latex allergy. The patient had known allergies to sulfamethoxazole; trimethoprim (BACTRIM). Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amoxicillin (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the left arm on 12Apr2021 at 10:30 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 04May2021 at 03:15, the patient experienced injection site swelling/redness/pain, chills, fever and tightening/numbness injection site. On 07May2021, fourth day of vaccination, the patient experienced shortness breath and pain in chest bending over. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events shortness breath, injection site swelling/redness/pain, chills, fever and pain in chest bending over was recovered with sequelae on an unknown date in May2021; while that of the tightening/numbness injection site was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected

Other Meds: AMOXICILLIN

Current Illness:

ID: 1652373
Sex: F
Age:
State:

Vax Date: 05/18/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Could barely feel a little soreness where the needle went in; Rash on area 10 days later; This is a spontaneous report from a contactable consumer (patient). A 79-years-old female patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Batch/Lot number, Expiration date and NDC number was not reported), via an unspecified route of administration on 18May2021 as dose 1, single (at the age of 79-years-old) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Patient stated that she had no problem at all for 24 hours and on May2021, patient could touch her arm and had a little soreness/could barely feel a little soreness where the needle went in. On May2021, 10 days later, patient developed a rash on area and wanted to know if she was allergic to something in the vaccine, specifically mentioning preservative. Patient also asked that should she get her second dose. The outcome of all the events was unknown. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652374
Sex: M
Age:
State:

Vax Date: 05/25/2021
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: sweats; This is a spontaneous report from a contactable consumer. This 70-Year-old male consumer reported for himself. A 70-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on 25May2021 (at the age of 70-year-old) as dose 2, single for COVID-19 immunization. Patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on an unspecified date (at the age of 70-year-old) as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, 2 weeks after the vaccination, the patient is experiencing mild sweats. Caller is wondering if he is supposed to get side effects on the 3rd week after both shots were given. The outcome of the events is not recovered at the time of report. No follow-up attempts possible. No further information expected.

Other Meds:

Current Illness:

ID: 1652375
Sex: F
Age:
State: PA

Vax Date: 05/24/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: experienced joint pain in opposite arm; a bit of tingling/numbness in my fingers; a bit of tingling/numbness in fingers.; Beginning symptom was just soreness in arm that received the vaccine.; This is a spontaneous report from a non-contactable consumer, the patient. An 18-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EWO167) via an unspecified route of administration in left arm on 24May2021 at 15:15 (at the age of 18-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma, allergy to regular laundry detergent or chemicals and short haired animal fur. Concomitant medications included vitamins nos (MANUFACTURER UNKNOWN) from an unknown date for an unknown indication and diphenhydramine hydrochloride (BENADRYL) from an unknown date for allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 24May2021 at 16:00, the patient experienced just soreness in arm that received the vaccine and a bit of tingling/numbness in her fingers. On 25May2021, the day after, the patient experienced joint pain in the opposite arm and vaccinated arm felt fine. All symptoms were no longer continued and the patient felt regular. No therapeutic measures were taken as a result of the reported events. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events soreness in arm, a bit of tingling/numbness in fingers and joint pain in the opposite arm was recovered on an unknown date in May2021. No follow-up attempts are possible. No further information is expected.

Other Meds: VITAMINS NOS; BENADRYL

Current Illness:

ID: 1652376
Sex: M
Age:
State: CA

Vax Date: 05/22/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: HIV test; Test Result: Negative ; Comments: Had to get tested for future wife; Test Name: STD Test; Test Result: Negative ; Comments: Had to get tested for future wife

Allergies:

Symptom List: Vomiting

Symptoms: Stress; a bunch of sores in the mouth, they bleed a lot/bleeding ulcers; a bunch of sores in the mouth, they bleed a lot/bleeding ulcers; The initial case was missing the following minimum criteria: specific number of patients. Upon receipt of follow-up information on 28Jul2021, this case now contains all required information to be considered valid. This is a spontaneous report from a contactable consumer (patient). This 27-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left on 22May2021 09:15 (at the age of 27 years) (Batch/Lot Number: EW0173) as a single dose for COVID-19 immunization. Concomitant medication included unspecified multivitamins. No additional vaccines were administered on the same date of the Pfizer suspect. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Patient previously received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in arm left on 01May2021 09:15 (Batch/Lot Number: EW0172). Historical vaccine information also included tetanus shot a year ago because he had cut a tendon in his hand. Hand got better, it was really intense. He thought he was going to lose his thumb, but he was quick with the medical tape. He had a miraculous recovery in 5 months. No AEs following prior vaccinations. He's never had any medical reactions or allergic reactions or anything before. Patient did have any side effects on 23May2021. On 24May2021 at 22:00, 48 hours after vaccination, patient had a massive out break of bleeding ulcers that lasted for 18 days. At first, patient was spitting out mouth and had falls of blood. Patient never had anything like this before. The doctor said that the patient would be fine and he healed. Patient had a bunch of sores in the mouth and they were "attached where the gum meets the tooth". He reported that these sore did not sting or burn but they bled a lot, and that they could be from stress. He had no sexual contact with anyone or shared drinks for a longtime with anyone. He did not know what it is, but it doesn't look like canker sores or herpes. He is not sure if this was a side effect. He took photos and sent them to a medical professional who said not to worry about it and that it would go away. The patient thinks it came from the vaccine. It is the only thing he has done differently. He has not had any tests. He talked to a person who said it didn't look like it needed to be tested and don't worry about it. Patient underwent tests which included STD Test in "Apr" with result negative (had to get tested for future wife), HIV test in "Jun" with result negative (had to get tested for future wife). Event bleeding ulcers was reported as serious with seriousness criteria: important medical event, required call to physician, but did not require the initiation of new medication/other treatment/procedure. The outcome of the event stress was unknown and of the other events was recovered on an unspecified date in Jun2021. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652377
Sex: F
Age:
State: MA

Vax Date: 05/21/2021
Onset Date: 05/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Tired; very sad; This is a spontaneous report from a contactable consumer, the patient. A 13-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21May2021 at 18:30 (at the age of 13-year-old) as a single dose for COVID-19 immunisation. The medical history and concomitant medications were not reported. The patient had no known allergies to food, medications or other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 26May2021 at 15:30, the patient felt tired and very sad. No previous signs of depression or anxiety ever before. The patient did not receive any treatment for the event. The adverse event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events tired and very sad was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652378
Sex: F
Age:
State:

Vax Date: 05/21/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: rash on my forearm; got itchy hands and feet; This is a spontaneous report from a contactable consumer (patient). A 20-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: unknown), via an unspecified route of administration on 21May2021 (at the age of 20-years-old) as dose 2, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), on an unspecified date as dose 1, single for COVID-19 immunization. The patient reported that she got his second dose on 21May2021 and 3-4 hours after he 'got itchy hands and feet'. Then she got a 'rash on her forearm' on 22May2021, but it went away within 30 min. She wanted to know whether it was common and whether was there anything that she could do for it. The outcome of the event itchy was unknown and rash was resolved on 22May2021. The lot number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Other Meds:

Current Illness:

ID: 1652379
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: tired; weak; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 65-years-old male patient received bnt162b2 (BNT162B2, PFZER-BIOTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as unknown, single dose for covid-19 immunization. No medical history and no concomitant medications were not reported. It was reported that patient stated since the vaccine dose he has felt weak and tired and patient wanted to know how long will it last. He was so tired, he need to rest when he is working. Patient asked for recommendations on any medication he can take for the symptoms. Reported seriousness was reported as non-serious. The outcome for the events was reported as unknown at the time of this report. Information about batch/lot number has been requested. Follow-up (23Aug2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.

Other Meds:

Current Illness:

ID: 1652380
Sex: F
Age:
State: IL

Vax Date: 05/20/2021
Onset Date: 05/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Swollen lymph node above collarbone on the side of vaccination.; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 20May2021 at 09:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. medical history was reported as none. The patient did not have allergies to medications, food, or other products. Concomitant medications included loratadine (CLARITIN 10MG), saccharomyces boulardii (FLORASTOR) and magnesium (MANUFACTURER UNKNOWN), all used for unknown indication from unspecified dates, unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.On 27May2021 at 11:00, the patient experienced swollen lymph node above collarbone on the side of vaccination. No therapeutic measures were taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event swollen lymph node was not recovered at the time of the report. The lot number for BNT162b2 was not provided and will be requested during follow up.

Other Meds: CLARITIN [LORATADINE]; FLORASTOR [SACCHAROMYCES BOULARDII]; MAGNESIUM

Current Illness:

ID: 1652381
Sex: F
Age:
State: UT

Vax Date: 05/27/2021
Onset Date: 05/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: feeling abnormal; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0191) via an unspecified route of administration in the left arm on 27May2021 at 08:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. The patient medical history included COVID-19. The patient had no allergies to food, medication or other products. The patient did not receive any other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0176) via an unspecified route of administration in the left arm on 06May2021 at 08:45 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19. On 27May2021 at 09:00, the patient stated that magnet sticks to her arm at injection site and there is a strong magnetic pull in other areas of her body/feeling abnormal. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event magnet sticks to her arm at injection site and there is a strong magnetic pull in other areas of her body/feeling abnormal was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am